FindTrial
Sign In

NSAID USED IN MESOTHERAPY VS NSAID INTRAMUSCOLAR INJECTION IN algodistrophy TREATMENT: A RANDOMIZED, CONTROLLED STUDY - ALGO-01

NSAID USED IN MESOTHERAPY VS NSAID INTRAMUSCOLAR INJECTION IN algodistrophy TREATMENT: A RANDOMIZED, CONTROLLED STUDY - ALGO-01

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2009-017160-17-IT
Enrollment
Unknown
Registered
2010-09-14
Start date
2010-02-24
Completion date
Unknown
Last updated
2014-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SUFFERED FROM ALGODISTROPHY PATIENTS MedDRA version: 9.1 Level: SOC Classification code 10029205 MedDRA version: 9.1 Level: SOC Classification code 10028395

Interventions

Trade Name: MOBIC*SOL INIET 2F 15MG/1,5ML Pharmaceutical Form: Solution for injection INN or Proposed INN: Meloxicam Concentration unit: mg milligram(s) Concentration type: equal Concentration number:

Sponsors

ISTITUTI ORTOPEDICI RIZZOLI
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: PATIENTS, WITHOUT LIMITS OF AGE, WITH SUPERIOR AND/OR INFERIOR LIMB ALGODISTROPHY IN TERAPHY FROM 5 WEEKS Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: NON COOPERATING PATIENTS; ALLERGIC TO THE DRUGS USED IN TERAPHY PATIENTS

Design outcomes

Primary

MeasureTime frame
Secondary Objective: PAIN CONTROL MOTOR FUNCTION;Primary end point(s): COMPARISON BETWEEN THE TECHNIQUES RELATED TO DELIVERY;Main Objective: COMPARISON BETWEEN THE TECHNIQUES RELATED TO DELIVERY—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026